Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial
Condition:   Inclusion Body Myositis Intervention:   Drug: Arimoclomol Sponsor:   Orphazyme Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of REGN2477+REGN1033 in Patients With Sporadic Inclusion Body Myositis
Condition:   Sporadic Inclusion Body Myositis Interventions:   Drug: REGN2477+REGN1033;   Drug: Matching placebo Sponsor:   Regeneron Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2018 Category: Research Source Type: clinical trials

Study of Pioglitazone in Sporadic Inclusion Body Myositis
Conditions:   Myositis;   Inclusion Body Myositis;   Muscular Diseases;   Musculoskeletal Disease;   Neuromuscular Diseases;   Nervous System Diseases Intervention:   Drug: Pioglitazone Sponsor:   Johns Hopkins University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Molecular Profile of the Evolution of Inclusion Body Myositis
Condition:   Inclusion Body Myositis Intervention:   Other: Blood collection Sponsor:   Centre Hospitalier Universitaire de Nice Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2017 Category: Research Source Type: clinical trials